Saturday 17 October 2026
Export NMTC’s income statement to Excel — free account
NeuroOne Medical Technologies Corporation
NMTC Healthcare Medical Devices
In the quarter to June 2026, revenue grew 16.3%, EPS fell 27.8% and free cash flow grew 26.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
0.96
0.08
−7.69%
Follow NMTC
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 5 | 3 | 3 | 6 |
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | 0.00 | 173.99 | 12.76 | 4.95 | 7.67 | 2.95 |
Altman Z-Score |
— | — | — | — | (6.97) | 7.82 | (2.07) | (9.23) | (22.18) | (3.72) |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | (24.79) | (15.40) | (10.40) | (27.14) | (57.27) | (19.57) |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | 46.25 | (20.83) | 26.57 | (5.81) | (9.94) | (23.38) |
Beneish M-Score |
— | — | — | — | — | — | 1.78 | — | — | 0.13 |
P/B ratio |
— | — | — | — | 82.77 | 6.45 | 2.82 | 2.70 | 32.24 | 5.04 |
Price to Tangible BV |
— | — | — | — | 89.55 | 6.58 | 2.85 | 2.74 | 35.11 | 5.08 |
EV/Sales |
— | — | — | — | 0.00 | 145.58 | 7.50 | 3.38 | 7.25 | 2.41 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | 0.00 | (4.11) | (2.11) | (0.89) | (2.27) | (10.26) |
EV/FCF |
— | — | — | — | 0.00 | (4.11) | (2.04) | (0.87) | (2.25) | (9.97) |
Quick Ratio |
0.77 | 0.01 | 0.00 | 0.15 | 1.71 | 5.88 | 3.61 | 2.97 | 0.74 | 3.40 |
Current Ratio |
0.85 | 0.01 | 0.00 | 0.17 | 1.76 | 6.17 | 3.93 | 4.08 | 2.09 | 4.44 |
Net Debt/EBITDA |
1.36 | (0.78) | (0.52) | 0.05 | 0.83 | 0.68 | 1.12 | 0.45 | 0.13 | 1.74 |
Debt/Assets |
36.36% | 0.00% | 766.71% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(1.03) | (0.48) | (0.38) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.73 | 0.04 | 0.20 | 0.33 | 0.51 | 1.50 |
Operating CF/Net income |
0.62 | 0.42 | 0.00 | 0.80 | 0.25 | 0.86 | 0.75 | 1.09 | 0.89 | 0.79 |
Capex/Depreciation |
0.00 | 0.00 | — | 0.00 | (2.57) | (0.83) | (2.57) | (2.45) | (0.35) | (0.18) |
Interest Coverage |
0.00 | (4.40) | (6.33) | (40.85) | (0.65) | (3,296.19) | (323.57) | (59.78) | — | — |
| 10.75% | 190.78% | 144.75% | 240.75% | (3,292.35%) | (230.81%) | (123.77%) | (149.61%) | (348.39%) | (91.34%) | |
| (56.61%) | (1,336.61%) | (1,399.51%) | (1,805.19%) | (515.46%) | (156.69%) | (96.33%) | (113.38%) | (182.93%) | (44.63%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (806.13%) | 0.00% | (526.10%) |
Return on Tangible Assets |
281.62% | 130.66% | 180.66% | 478.76% | (694.12%) | (157.07%) | (106.03%) | (196.15%) | (434.58%) | (44.06%) |
Average Days of Receivables |
— | — | — | — | 0.00 | 72.55 | 5.72 | 0.00 | 18.67 | 38.16 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 107.74% | 1,615.23% | 232.52% | 203.68% | 146.69% | 41.19% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 246.70% | 2,576.26% | 329.22% | 203.26% | 228.84% | 61.04% |
Intangible Assets out of Total Assets |
0.24 | 0.00 | 0.92 | 0.34 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | — | 95.30% | 737.94% | 44.68% | 32.44% | 38.94% | 10.45% |
Graham Net Nets |
— | — | — | — | 0.01 | 0.14 | 0.33 | 0.32 | 0.00 | 0.18 |
Graham Number |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | (40.02%) | (23.74%) | (37.27%) | (69.88%) | (46.46%) | (9.01%) |
Free Cash Flow Yield |
— | — | — | — | 0.00% | (20.36%) | (28.82%) | (78.69%) | (42.01%) | (8.18%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 2.13 | 0.14 | 0.79 | 1.13 | 0.77 | 1.81 |
Operating CF per Share |
(0.07) | (0.96) | 0.00 | (1.37) | (3.79) | (4.82) | (2.82) | (4.27) | (2.47) | (0.42) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.14) | (0.04) | (0.10) | (0.12) | (0.03) | (0.01) |
Free Cash Flow per Share |
(0.07) | (0.96) | 0.00 | (1.37) | (3.93) | (4.86) | (2.92) | (4.39) | (2.50) | (0.44) |
Cash per Share |
0.22 | 0.01 | 0.00 | 0.07 | 4.47 | 3.87 | 4.18 | 1.76 | 0.33 | 0.98 |
Shareholders Equity per Share |
(0.11) | (2.29) | (1.57) | (0.31) | 2.29 | 3.68 | 3.60 | 2.07 | 0.18 | 1.06 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.11) | (2.29) | (1.57) | (0.31) | 2.29 | 3.68 | 3.60 | 2.07 | 0.18 | 1.06 |
Free Cash Flow |
(0.18) | (2.11) | — | (5.40) | (3.55) | (8.67) | (7.79) | (13.26) | (11.13) | (2.92) |
Working Capital |
(0.10) | (3.87) | (3.78) | (1.47) | 1.80 | 6.11 | 9.08 | 5.52 | 2.42 | 7.92 |
Capital Expenditures |
— | (0.09) | — | (0.12) | (0.12) | (0.07) | (0.28) | (0.38) | (0.12) | (0.08) |
Net Current Asset Value |
(0.45) | (5.25) | (4.60) | (1.47) | 1.46 | 5.91 | 8.96 | 5.47 | 0.08 | 6.51 |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | — | 0.06 | 0.28 | 0.13 | 0.11 | 0.03 | 0.01 |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | — | 0.53 | 0.29 | 0.36 | 0.30 | 0.29 | 0.84 | 1.75 |
Cash ROIC |
(33.09%) | 81.43% | 0.00% | 552.36% | (58.13%) | (64.44%) | (37.57%) | (114.62%) | (487.82%) | (21.40%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 0.00 | 52.02 | 0.00 | 32.92 | 16.79 |
Accounts Payable Turnover |
0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.33 | 1.86 | 2.77 | 3.88 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.60 | 1.23 | 1.09 | 1.63 |
Average Days of Payables |
9.48 | 0.00 | 0.00 | 0.00 | 0.00 | 699.57 | 1,399.22 | 167.16 | 158.29 | 93.22 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | — | 130.05 | 1,062.57 | 421.32 | 405.28 | 205.44 |
Average Receivables |
— | — | — | — | — | — | 0.04 | — | 0.10 | 0.72 |
Average Payables |
0.38 | — | — | — | 0.38 | 0.65 | 0.73 | 0.81 | 0.86 | 1.02 |
Average Inventory |
— | — | — | — | — | — | 0.40 | 1.22 | 2.18 | 2.43 |
Average Assets |
0.50 | 0.38 | 0.49 | 0.38 | 2.65 | 6.35 | 10.38 | 10.46 | 6.73 | 8.08 |
Average Common Equity |
(2.65) | (2.65) | (4.72) | (2.82) | 0.41 | 4.31 | 8.08 | 7.93 | 3.54 | 3.95 |
Columns are period end dates